Connection
Mark Boguniewicz to Chemokine CCL17
This is a "connection" page, showing publications Mark Boguniewicz has written about Chemokine CCL17.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.243 |
|
|
|
-
Beck LA, Muraro A, Boguniewicz M, Chen Z, Zahn J, RodrÃguez Marco A. Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol. 2025 Jan; 155(1):135-143.
Score: 0.224
-
Beck LA, Boguniewicz M, Hata T, Schneider LC, Hanifin J, Gallo R, Paller AS, Lieff S, Reese J, Zaccaro D, Milgrom H, Barnes KC, Leung DY. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol. 2009 Aug; 124(2):260-9, 269.e1-7.
Score: 0.020